Baudin E, Goichot B, Berruti A, Hadoux J, et al. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial. Lancet 2024;403:1061-1070.
PMID: 38402886